Market Overview
The France pet nutraceuticals market encompasses functional foods, treats, and dietary supplements formulated with bioactive ingredients that provide health benefits beyond basic nutrition for companion animals. The market generated $339.9 million in revenue in 2023 and is forecast to reach $530.0 million by 2030 at a 6.6% CAGR from 2024 to 2030. This positions France as a key Western European market within the broader European pet nutraceuticals sector valued at $1.81 billion in 2025.
- •France market value: $339.9 million (2023) to $530.0 million (2030)
- •European market size: $1.81 billion (2025) projected to reach $2.6 billion (2030)
- •Global context: Worldwide market at $6.78 billion (2023) growing to $10.49 billion (2030)
Growth Drivers
Escalating pet humanization remains the primary catalyst, as French pet owners increasingly treat companion animals as family members and allocate more household spending toward preventive healthcare and longevity products. An aging pet population creates sustained demand for nutritional products that support joint mobility, cognitive function, skin and coat health, and digestive wellness. Product innovation from major manufacturers, combined with growing veterinary endorsement of nutritional interventions, is expanding consumer awareness and trial of nutraceutical offerings.
- •Pet humanization driving premiumization and increased spending on companion animal health
- •Aging pet population creating sustained demand for preventive and therapeutic supplements
- •Veterinary community advocacy for nutrition-based health solutions boosting market credibility
Segmentation and Regional Analysis
Vitamins and minerals constitute the largest revenue-generating ingredient category across Europe, with functional segments targeting joint support, skin and coat condition, and digestive health experiencing particularly strong growth rates. Within France, the cat segment has emerged as a notable contributor to the supplements category, reflecting rising cat ownership and owner willingness to invest in feline-specific wellness products. The French market represents a mature but expanding segment of Western Europe, where the regional pet nutraceuticals sector outpaces global growth averages.
- •Vitamins and minerals lead as the dominant ingredient segment in the European market
- •Cats represent a key and growing segment within France's pet supplements market
- •European market CAGR of 7.63% exceeds the global average of 6.4%
Trends and Outlook
What are the recent trends and outlook?
The market is positioned for continued expansion through 2030, with France expected to add nearly $190 million in cumulative value over the forecast period. Emerging trends include demand for natural and organic formulations, breed-specific and life-stage targeted products, and veterinary-grade supplements available through clinical channels. E-commerce and direct-to-consumer platforms are gaining traction as French pet owners increasingly research and purchase health products online, complementing traditional veterinary clinics and brick-and-mortar retail distribution.
- •France projected to reach $530 million by 2030 at 6.6% CAGR, adding substantial market value
- •Natural, organic, and breed-specific formulations emerging as key product differentiators
- •Digital commerce channels accelerating as primary discovery and purchase platforms
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.